PCN338 KEY DRIVERS OF HEALTH TECHNOLOGY ASSESSMENT DECISIONS FOR RELAPSED-REFRACTORY MULTIPLE MYELOMA TREATMENTS; A COUNTRY COMPARISON.

Abstract

Authors

S. Horsburgh L. Nelson S. Chadda

Full Text Cite This Article
Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×